Hakim Nasrat A 4
4 · ELITE PHARMACEUTICALS INC /NV/ · Filed Apr 2, 2024
Insider Transaction Report
Form 4
Hakim Nasrat A
DirectorPresident & CEO
Transactions
- Award
Common Stock
2024-03-29+49,534,368→ 216,649,250 total
Holdings
- 2,700,000(indirect: By IRA)
Common Stock
- 2,223,147(indirect: by Kristine Hakim)
Common Stock
Footnotes (1)
- [F1]Shares issued in settlement of compensation owed to the Reporting Person pursuant to his Employment Agreement with the issuer, dated August 1, 2013, as amended.